The FDA gave the green light for Helius Medical Technologies to begin enrolling patients in a clinical trial of its portable neuromodulation stimulator in patients with chronic balance disorders due to mild-to-moderate brain injury.
Align, ClearCorrect move to settle infringement litigation
GI Dynamics exercises 1-for-10 reverse split
GI Dynamics (ASX:GID) said it conducted a 1-for-10 reverse stock split in an effort to boost its flagging share price.
Positron conducts 1-for-400 reverse stock split
Cardiac imaging specialist Positron Corp. (OTC:POSC) said it conducted a 1-for-400 reverse stock split yesterday.
Tasso, GenTegra win DARPA grant for blood-draw tech
Tasso said it won a $2.9 million grant from the U.S. Defense Advanced Research Projects Agency to continue work on an integrated blood-sampling device that can be used in war zones.
The grant to Tasso and development partner GenTegra was awarded based on progress the companies have made under a previously issued Phase II SBIR contract, Madison, Wis.-based Tasso said.